Rocket Pharmaceuticals, Inc.
Rocket Pharmaceuticals develops genetic therapies for rare genetic diseases, focusing on AAV-based gene therapy for inherited cardiomyopathies and related disorders.
10-QNov 16Latest SEC filing
Nov 12Latest story
November 2026
October 2026
September 2026
August 2026
June 2026